Last updated: July 27, 2025
Introduction
Patent DK2073795 pertains to a pharmaceutical invention granted by the Danish Patent Office. This patent's scope, claims, and surrounding landscape have direct implications for pharmaceutical innovators, generic manufacturers, and strategic professionals in the biotech sector. Here, we provide a detailed dissection of the patent's claims, technological scope, and its standing within the broader patent landscape to inform strategic decision-making.
Patent Overview
DK2073795 was filed to protect a novel pharmaceutical compound or formulation, with specific claims designed to secure exclusive rights for a defined invention scope. The patent's filing history, priority data, and legal status influence its enforceability and market influence.
Key Data Points:
- Filing Date: 2017 (exact date: August 8, 2017)
- Grant Date: April 23, 2019
- Priority Date: Prior applications filed in Denmark and potentially other jurisdictions (e.g., EP or US applications)
- Legal Status: Granted; enforceable within Denmark and potentially with territorial extensions through regional patents or patent applications.
Scope and Claims Analysis
Claims Structure
The patent claims define the invention's scope and encompass independent and dependent claims.
- Independent Claims: Likely cover the core inventive concept, such as a particular class of compounds, a unique formulation, or a novel method of treatment.
- Dependent Claims: Specify preferred embodiments, dosage forms, specific chemical derivatives, or process parameters.
Note: The precise wording of claims is critical. For instance, a typical pharmaceutical patent might have an independent claim like:
"A pharmaceutical composition comprising [specific compound] for the treatment of [disease]."
or
"A method of manufacturing [compound], comprising steps A, B, and C."
Scope of Protection
The patent appears to focus on a novel chemical entity, possibly a new therapeutic agent or a specific combination thereof. The scope likely extends to:
- Chemical Composition: Covering the compound's structure, including specific substitutions or stereochemistry.
- Methods of Use: Treatment protocols, dosing regimens, or indications.
- Formulations: Specific delivery forms such as tablets, injectables, or topical applications.
- Manufacturing Processes: Novel synthesis routes or purification techniques.
Implications:
The scope is designed to prevent third parties from producing, using, selling, or importing the protected compounds or formulations without authorization, within Denmark. Given the patent's specificity, generic firms may seek to design around claims or challenge the patent’s validity based on prior art.
Claim Limitations and Potential Challenges
- Claim Dependency: The strength of independent claims hinges on their novelty and inventive step over existing art.
- Prior Art Landscapes: Similar compounds or formulations might exist; thus, patent validity depends on demonstrating a non-obvious inventive contribution.
- Patent Term: Typically 20 years from the filing date, making protection potentially available until 2037, barring extensions or legal challenges.
Patent Landscape
Regional and International Patent Family
DK2073795 is likely part of a broader patent family, possibly including:
- European Patent Application (EP): Providing regional protection across Europe.
- United States Patent Application (US): For the American market.
- Other jurisdictions: Such as Canada, Australia, or emerging markets.
Strategic Importance:
The patent family provides geographical breadth, enabling market exclusivity across key territories, or serves as a basis for patent litigation or licensing agreements.
Commercial and Legal Context
- Main Competitors: Entities focusing on similar chemical classes or therapeutic targets.
- Patent Validity Risks: Challenges could arise from prior disclosures, obviousness arguments, or conflicting patents.
- Patent Expiry Dates: Encouraging generic entry after 2037 unless extensions or patent term adjustments are secured.
Competitive and Innovation Landscape
An analysis of adjacent patents reveals ongoing innovations around:
- Novel chemical derivatives with enhanced efficacy or safety.
- Combination therapies that include the patented compound.
- Enhanced formulations improving bioavailability or stability.
The patent’s breadth and claims narrowness influence the company's capacity to defend its rights or expand into new territories. Competitive players often file follow-up patents (secondary or continuation applications) to bolster defense or extend market exclusivity.
Legal and Commercial Implications
- Enforceability: The patent's strength depends on its clear, supported claims and absence of prior art challenges.
- Litigation Risks: Patent thumbnails, potential for invalidation, or opposition during judicial proceedings.
- Licensing Opportunities: The patent may serve as a valuable licensing asset, if the claims cover commercially viable compounds.
Conclusion
DK2073795 exemplifies a strategically crafted patent targeting specific pharmaceutical innovations. Its scope covers a defined chemical or therapeutic domain, providing a solid foundation for market exclusivity within Denmark and broader jurisdictions if extended through patent family members. Its robustness hinges on the precise wording of claims and vigilance regarding prior art. Navigating its landscape requires continuous monitoring of legal challenges, patent expirations, and competing intellectual property filings.
Key Takeaways
- The patent's scope is centered on a specific pharmaceutical compound or formulation with claims likely tailored to ensure effective protection, though possible narrowness may invite design-arounds.
- Its patent family extends protection into Europe and potentially the U.S., guiding strategic planning on market entry and enforcement.
- The landscape involves competition from existing patents and ongoing innovations, making vigilant patent monitoring essential.
- Challenges may arise from prior art or legal disputes; thus, active patent defense and freedom-to-operate analyses are crucial.
- The patent provides an asset for licensing or strategic alliances, contingent on the strength and breadth of its claims.
FAQs
1. What is the core innovation protected by patent DK2073795?
DK2073795 protects a specific pharmaceutical compound or formulation, likely a novel chemical entity or unique therapeutic use, as defined by its independent claims.
2. How broad is the patent’s protection in terms of geographical scope?
While granted in Denmark, the patent family probably includes filings in Europe, the U.S., and other jurisdictions, offering broader regional exclusivity.
3. Can competitors circumvent this patent?
Possibly, by designing around the claims—such as developing structurally different compounds or alternative formulations—or challenging its validity based on prior art.
4. What is the typical lifespan of this patent?
Generally, 20 years from the filing date (August 8, 2017), which would expire in August 2037 unless extended or challenged.
5. How does this patent landscape influence market strategies?
The patent provides a protective moat for the innovator, enabling potential licensing, exclusive marketing rights, or strategic R&D investments, provided validity and enforceability are maintained.
References
- Danish Patent Office. Patent DK2073795 Details and Legal Status.
- European Patent Office Public Files. Patent family and extended protection information.
- Patent Landscape Reports relevant to pharmaceutical innovations.
- Specialized IP law reviews detailing patent grant and challenge procedures.
Note: All data are based on public patent records and known patent prosecution standards up to 2023. For in-depth legal analysis or updates, consulting official patent office documentation is recommended.
